Kurome Therapeutics
Manish Bhandari an Oncologist, educated Harvard Medical School & Univ of Michigan with 15 year oncology practice experience. He is an Investigator in over 24 oncology therapeutic/targeted therapy trials in malignant hematology and Oncology.
This person is not in the org chart
This person is not in any offices
Kurome Therapeutics
Kurome Therapeutics is developing therapies that target cancer cells that have co-opted immune signaling pathways in order to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.